A detailed history of Cottonwood Capital Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cottonwood Capital Advisors, LLC holds 456 shares of LLY stock, worth $357,125. This represents 0.32% of its overall portfolio holdings.

Number of Shares
456
Previous 463 1.51%
Holding current value
$357,125
Previous $419,000 3.82%
% of portfolio
0.32%
Previous 0.35%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$772.14 - $960.02 $5,404 - $6,720
-7 Reduced 1.51%
456 $403,000
Q2 2024

Jul 16, 2024

SELL
$724.87 - $909.04 $5,798 - $7,272
-8 Reduced 1.7%
463 $419,000
Q1 2024

Apr 26, 2024

SELL
$592.2 - $792.28 $27,833 - $37,237
-47 Reduced 9.07%
471 $366,000
Q4 2023

Feb 09, 2024

BUY
$525.19 - $619.13 $272,048 - $320,709
518 New
518 $301,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $744B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cottonwood Capital Advisors, LLC Portfolio

Follow Cottonwood Capital Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cottonwood Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cottonwood Capital Advisors, LLC with notifications on news.